Cleerly

Cleerly's CLARIFY 2 study demonstrates the efficacy of its non-invasive AI-enabled CCTA approach for heart disease evaluation

3 min read

CLARIFY 2 Affirms Cleerly Over Invasive Heart Disease Evaluation Methods

Findings from Cleerly's groundbreaking echo the recent American College of Cardiology guidelines on the use of CCTA for non-invasive heart disease evaluation.

Read More »

2 min read

Cleerly Product Release:  Taking Precision Heart Care to the Next Level

As Cleerly makes its way into the clinical workflow of health systems and providers across the US, we are learning valuable information about how to...

Read More »